FASN and breast cancer: A significant body of research has evaluated the lipogenic role of FASN in breast cancer [27-29], and previous work by Mazzarelli et al. (2007) has reported on the expression of CPT1, the rate-limiting enzyme governing long-chain fatty acid catabolism, at the mRNA and protein levels in MCF-7 cells [30].